Answers are grounded in this paper and cite their sources.
, termed Amuc_1100, could be strong candidate for future drug development. In conclusion, as plants and its related knowledge, known as pharmacognosy, have been the source for designing drugs over the last century, we propose that microbes and microbiomegnosy, or knowledge of our gut microbiome, can become a novel source of future therapies.
No takes yet. Share an insight, caveat, or question.
Cani et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: